title: FDA post-marketing safety decisions.
authors.affiliation: New York State Psychiatric Institute, Columbia University, New York, NY 10032, USA. donaldk737@aol.com
authors.forename: Donald F
authors.initials: DF
authors.lastname: Klein
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards; D000928:Antidepressive Agents / Q000009:adverse effects; D004348:Drug Labeling / Q000592:standards; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards*; D018570:Risk Assessment / Q000592:standards; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
chemical_list: D000928:Antidepressive Agents